308 related articles for article (PubMed ID: 10030087)
1. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence].
Pizarro M; Lissi E; Reyes J; Holmgren J
Rev Med Chil; 1998 Oct; 126(10):1165-72. PubMed ID: 10030087
[TBL] [Abstract][Full Text] [Related]
2. [Selenium and vitamin E in patients with progressive muscular dystrophy].
Voirin J; Deschrevel G; Guincestre JY; Foucault P; Bureau F; Duhamel JF
Ann Pediatr (Paris); 1990 Jun; 37(6):377-9. PubMed ID: 2400191
[TBL] [Abstract][Full Text] [Related]
3. Enhanced urinary spontaneous luminescence in Duchenne muscular dystrophy.
Reyes J; Salim-Hanna M; Lissi EA; Videla LA; Holmgren J
Free Radic Biol Med; 1994 Jun; 16(6):851-3. PubMed ID: 8070691
[TBL] [Abstract][Full Text] [Related]
4. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
[TBL] [Abstract][Full Text] [Related]
5. Altered polyamine excretion in Duchenne muscular dystrophy.
Russell DH; Stern LZ
Neurology; 1981 Jan; 31(1):80-3. PubMed ID: 7192830
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous urinary visible luminescence: characteristics and modification by oxidative stress-related clinical conditions.
Lissi EA; Salim-Hanna M; Videla LA
Braz J Med Biol Res; 1994 Jul; 27(7):1491-505. PubMed ID: 7874017
[TBL] [Abstract][Full Text] [Related]
7. Measurement of skeletal muscle mass in Duchenne muscular dystrophy: use of 24-h creatinine excretion.
Franciotta D; Zanardi MC; Albertotti L; Orcesi S; Berardinelli A; Pichiecchio A; Uggetti C; Tagliabue A
Acta Diabetol; 2003 Oct; 40 Suppl 1():S290-2. PubMed ID: 14618496
[TBL] [Abstract][Full Text] [Related]
8. Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus.
Giannini C; Lombardo F; Currò F; Pomilio M; Bucciarelli T; Chiarelli F; Mohn A
Diabetes Metab Res Rev; 2007 Oct; 23(7):539-46. PubMed ID: 17266173
[TBL] [Abstract][Full Text] [Related]
9. Effect of hyperbaric oxygen and vitamin C and E supplementation on biomarkers of oxidative stress in healthy men.
Bader N; Bosy-Westphal A; Koch A; Rimbach G; Weimann A; Poulsen HE; Müller MJ
Br J Nutr; 2007 Oct; 98(4):826-33. PubMed ID: 17475085
[TBL] [Abstract][Full Text] [Related]
10. A pilot trial of plasma infusions in Duchenne muscular dystrophy.
Arthur H; Austin L; Roberts LJ
Aust Paediatr J; 1988; 24 Suppl 1():24-30. PubMed ID: 3202736
[TBL] [Abstract][Full Text] [Related]
11. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
[TBL] [Abstract][Full Text] [Related]
12. [Delayed diagnosis of Duchenne muscular dystrophy in Chile].
de los Angeles Avaria M; Kleinsteuber K; Herrera L; Carvallo P
Rev Med Chil; 1999 Jan; 127(1):65-70. PubMed ID: 10436681
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
[TBL] [Abstract][Full Text] [Related]
14. Standing balance in healthy boys and in children with Duchenne muscular dystrophy.
Kelly CR; Redford JB; Zilber S; Madden PA
Arch Phys Med Rehabil; 1981 Jul; 62(7):324-7. PubMed ID: 7247659
[TBL] [Abstract][Full Text] [Related]
15. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G
Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
[TBL] [Abstract][Full Text] [Related]
16. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E supplementation reduces oxidative stress in beta thalassaemia intermedia.
Pfeifer WP; Degasperi GR; Almeida MT; Vercesi AE; Costa FF; Saad ST
Acta Haematol; 2008; 120(4):225-31. PubMed ID: 19218790
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
Stewart PM; Walser M; Drachman DB
Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016
[TBL] [Abstract][Full Text] [Related]
19. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
Airenne AL; Westermarck T
Med Biol; 1984; 62(2):154. PubMed ID: 6471936
[No Abstract] [Full Text] [Related]
20. Effects of vitamin E depletion/repletion on biomarkers of oxidative stress in healthy aging.
Winklhofer-Roob BM; Meinitzer A; Maritschnegg M; Roob JM; Khoschsorur G; Ribalta J; Sundl I; Wuga S; Wonisch W; Tiran B; Rock E;
Ann N Y Acad Sci; 2004 Dec; 1031():361-4. PubMed ID: 15753170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
